<DOC>
	<DOCNO>NCT00004414</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare conjugate bilirubin level serum bile acid level severely premature newborn long term parenteral nutrition give either sincalide placebo . II . Compare morbidity mortality rate patient population . III . Evaluate ultrasonographic image hepatobiliary tree 1 2 year administration sincalide placebo ass development biliary sludge biliary stone formation .</brief_summary>
	<brief_title>Sincalide ( Cholecystokinin Octapeptide ) Versus Placebo Neonates High Risk Developing Parenteral Nutrition Associated Cholestasis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , placebo control , double blind , multicenter study . Patients stratify accord prematurity surgical group . Patients randomize receive either placebo sincalide IV 10 15 minute every 12 hour total 8 week therapy administer great 50 % nutrition enteral . Patients follow maximum 2 year . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Cholestasis</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Severely premature neonate ( less 1000 g birth estimate gestational age great 28 week ) require great 50 % caloric requirement parenteral mean within 7 day birth OR Neonates one follow surgical condition : Necrotizing enterocolitis Gastroschisis Severe jejunalileal atresia within 7 day diagnosis Prior/Concurrent Therapy Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : See Disease Characteristics No cardiovascular ( thoracotomy ) major gastrointestinal surgery ( laparotomy ) newborn period Other : No prior concurrent ursodeoxycholic acid No concurrent use extracorporeal life support Patient Characteristics Performance status : Not specify Hematopoietic : Not specify Hepatic : Conjugated bilirubin great 1.0 mg/dL No primary secondary liver disease No hepatic insufficiency document either biopsy cirrhosis elevate prothrombin time without evidence systemic coagulopathy administration anticoagulant Renal : No renal failure indicate progressive increase creatinine level Other : No hemodynamic instability No document communicable infection ( include infectious hepatitis HIV ) No metabolic pathway defect associate liver dysfunction neonatal period include hereditary fructose intolerance , galactosemia due transferase deficiency , neonatal tyrosinemia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Days</maximum_age>
	<verification_date>May 1999</verification_date>
	<keyword>cholestasis</keyword>
	<keyword>gastrointestinal disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>